Tue, Feb 24, 2026
Volume 10, Issue 2 (12-2023)
vacres 2023, 10(2): 9-10 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Marandi V. Mitigation of Scale-Up Risks in Technology Transfer of Vaccines and other Bioproducts. vacres 2023; 10 (2) :9-10
URL: http://vacres.pasteur.ac.ir/article-1-346-en.html
URL: http://vacres.pasteur.ac.ir/article-1-346-en.html
Pasteur Institute of Iran
Abstract: (3123 Views)
This article explores the subject of mitigating the risks associated with technology transfer in the bioproduction sector such as vaccine industries, which is a challenging and multifaceted process. Based on an examination of case study data, industry reports, and insights gained from over 20 years of bioprocessing experience, it is evident that a comprehensive understanding of the variables involved and meticulous attention to detail are necessary for successful scale-up. Key technological factors include strict regulatory compliance, equipment compatibility, and optimization of process parameters. Organizations can minimize the risks associated with scaling up bioproduction processes and effectively manage the complexities of technology transfer by implementing data-driven strategies and advanced modeling tools.
Type of Study: Short communication |
Subject:
Vaccine production and manufacturing
Received: 2024/06/30
Received: 2024/06/30
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.